Business

Neurim Pharmaceuticals markets its new drugs through strategic alliances with reputable marketing and distribution partners on whose marketing expertise we rely.

Neurim has so far established marketing and sales agreements with Teva, Takeda, Aspen Pharmacare, DKSH, Flynn, Medice, Italfarmaco, Biocodex, Kuhnil Pharm, Fidia, Juste and Biopas.
We are actively seeking additional strategic alliances.

Please feel free to contact us:

Dr. Hansjoerg Jakubetz
Director Corporate Business Development
Email: business@neurim.com

  • Text size: A A A
  • Circadin
  • Recent news

    • Positive Phase III Results for Neurim Pharmaceuticals’ Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder (ASD) Presented at the World Sleep Congress in Prague
    • Neurim Pharmaceuticals’ New Paediatric Prolonged-Release Melatonin (“PedPRM”) to Be Marketed by Flynn Pharma in UK and Ireland
    • Positive Results of Pivotal Phase III Study of Pediatric Prolonged-Release Melatonin (PedPRM) for Insomnia in Children with Autism Spectrum Disorder (ASD) to be Presented at the World Sleep Congress in Prague on October 9th
  • Partners

    Partners